Eledon Pharmaceuticals, Inc. (ELDN) vs Cartesian Therapeutics, Inc. (RNAC)

Eledon Pharmaceuticals, Inc. and Cartesian Therapeutics, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Cartesian Therapeutics, Inc. are of similar size ($230.6M and $228.3M). Across the 9 metrics below, Cartesian Therapeutics, Inc. leads on 5 and Eledon Pharmaceuticals, Inc. on 4.

Valuation

Metric ELDN RNAC Biotechnology median
P/E n/m n/m 7.88
P/S n/m 123.01 11.47
P/B 9.16 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 75.40 10.73
Earnings yield (34.21%) (80.03%) (28.84%)
Free cash flow yield (24.43%) (36.00%) (23.03%)

Profitability

Metric ELDN RNAC Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (236.51%) 236.88% (57.72%)
Return on assets (72.74%) (42.77%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELDN RNAC Biotechnology median
Revenue growth (TTM) — (94.81%) 5.64%
EPS growth (last fiscal year) 30.67% (11.80%) —
Revenue growth, 5-year CAGR — (29.96%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELDN RNAC Biotechnology median
Debt to equity 0.00 (0.42) 0.00
Current ratio 7.90 7.48 4.73
Net debt to EBITDA 1.60 0.89 0.96

Dividend

Metric ELDN RNAC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ELDN RNAC Biotechnology median
Market cap 228.34m 230.55m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack